This content is only available within our institutional offering.
30 Oct 2019
BAYER: Q3 2019 globally in line with a confirmed recovery in Consumer Health | SELL | EUR64(-5%)
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
BAYER: Q3 2019 globally in line with a confirmed recovery in Consumer Health | SELL | EUR64(-5%)
Bayer AG (BAYN:WBO) | 0 0 0.5% | Mkt Cap: 80,975m
- Published:
30 Oct 2019 -
Author:
Eric Le Berrigaud -
Pages:
3
BAYER - SELL | EUR64(-5%)
Q3 2019 globally in line with a confirmed recovery in Consumer Health
A better Q3 2019 than was Q2
Crop Science: better-than-expected too
Pharmaceuticals without any surprise – Loss of the anti-TFPI
Consumer Health: the recovery in the making
No change to our rating